Terminated PHASE3 INTERVENTIONAL 2-arm NCT00929630

Seton or Glue for Trans-sphincteric Anal Fistulas

Seton or Glue for Trans-sphincteric Anal Fistulas. A Prospective Randomised Clinical Trial

Sponsor: Societa Italiana di Chirurgia ColoRettale

Interventions Fistula closing with biological glue Seton positioning into the fistula tract glue (Tissucol) treatment transsphincteric Seton positioning

Updated 5 times since 2017 Last updated: Sep 15, 2009 Started: Jan 31, 2006 Primary completion: May 31, 2007 Completion: Jun 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Evident advantages of one treatment (seton) over the other (Tissucol Glue)

Listed as NCT00929630, this PHASE3 trial focuses on Anal Fistulas and remains terminated or withdrawn. Sponsored by Societa Italiana di Chirurgia ColoRettale, it has been updated 5 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

Jan 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Societa Italiana di Chirurgia ColoRettale

Data source: Societa Italiana di Chirurgia ColoRettale

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bari, Italy